TBPH icon

Theravance Biopharma

98 hedge funds and large institutions have $770M invested in Theravance Biopharma in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$79K
Net Calls
Net Calls Change

Top Buyers

1 +$43.3M
2 +$30.8M
3 +$25.4M
4
BG
Baupost Group
Massachusetts
+$19.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3M

Top Sellers

1 -$10.2M
2 -$7.52M
3 -$5.24M
4
Northern Trust
Northern Trust
Illinois
-$3.7M
5
RA
Royce & Associates
New York
-$2.2M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$198M
2
$167M
3
$74.4M
4
$55.6M
5
$40.5M
6
$25.4M
7
$23.2M
8
$18.3M
9
$16.1M
10
$15.9M
11
$14.8M
12
$11.5M
13
$10.7M
14
$7.84M
15
$7.37M
16
$6.03M
17
$5.57M
18
$4.81M
19
$4.78M
20
$4.08M
21
$3.64M
22
$3.41M
23
$3.07M
24
$2.83M
25
$2.81M